Industry Intel - Conference Recaps and Thought Leadership Article

Nobody Is Going to Tell You What to Screen

Across 2026, FinCEN withdrew, delayed, or eliminated one prescriptive AML mandate after another. In the same year, it proposed a rule that makes your program harder to defend, not easier. The checkbox is receding; the judgment is yours.

Mandates are receding, but the standard stays

On November 6, 2026, FinCEN and the Federal Reserve jointly withdrew a proposed rule that had been pending since 2020. The proposal would have lowered the recordkeeping and Travel Rule threshold for certain cross-border transfers from $3,000 to $250, and it would have written convertible virtual currency into the Travel Rule’s definition of money. After a five-year fight over privacy and feasibility, the agencies simply pulled it. The $3,000 threshold stays exactly where it was.

If you read that as the compliance burden lifting, read it again. The transfers the proposal targeted did not become less risky because the agencies declined to make a lower threshold mandatory. Small-dollar cross-border structuring and virtual-currency flows that move value across borders are exactly the same risks today as they were on November 5. What changed is who decides whether to watch them. The regulator stepped back from prescribing a number. The institution now owns the judgment, and the consequences that follow from it.

A year of receding mandates

The cross-border withdrawal is not an isolated event. It is the clearest recent example of a pattern that ran through all of 2026, as one prescriptive requirement after another was narrowed, delayed, or removed:

  1. The cross-border Travel Rule proposal, withdrawn. The 2020 plan to drop the threshold to $250 and bring crypto into the Travel Rule is gone (November 6, 2026). The existing $3,000 recordkeeping standard remains in force, but no new prescriptive floor replaces it.
  2. Beneficial ownership reporting, eliminated. In August 2026, FinCEN finalized a rule permanently exempting U.S. companies and U.S. persons from Corporate Transparency Act beneficial ownership reporting, and removing the data already collected. The central registry many teams had built workflows around is not coming.
  3. The investment adviser AML rule, delayed. The AML program and suspicious activity reporting requirements for registered and exempt reporting advisers, originally effective January 1, 2026, were postponed to January 1, 2028, with FinCEN signaling it will revisit the substance through a future rulemaking.

Each of these is a decision to prescribe less: fewer mandated thresholds, fewer mandatory data collections, fewer fixed effective dates. Taken together they describe a clear direction of travel. The era of the detailed federal checklist is receding. For a compliance function that has spent two decades learning to satisfy prescriptive requirements, that is a harder environment, not an easier one.

A withdrawn rule is not a withdrawn risk. When the regulator stops naming the threshold, the institution inherits the decision about where its real exposure sits.

The standard did not loosen. It sharpened.

Here is the part that gets lost when deregulation makes headlines. In the same year it was pulling back prescriptive mandates, FinCEN proposed a rule that raises the bar on everything that remains. On April 7, 2026, it issued a proposed AML/CFT Program Rule (comments closed June 9, 2026) that would rewrite the baseline for what a compliance program has to be.

The current program rules are built on a familiar set of pillars: policies and procedures, an officer, training, independent testing, and customer due diligence. You could, in principle, satisfy them on paper. The proposed rule replaces that posture with a single demanding standard: your program must be effective and reasonably designed, and it must be implemented in all material respects. FinCEN was explicit that a program that looks compliant but does not actually work, what it called a paper program, would not satisfy the requirement.

What an effective and reasonably designed program now asks.  The proposal requires an ongoing risk assessment process that evaluates money laundering and terrorist financing risk across products, services, delivery channels, customers, and geographies, and that is updated promptly when something materially changes a risk. It requires institutions to review the national AML/CFT priorities and incorporate them as appropriate to their own risk profile, and it warns that a perfunctory review will not count. It separates establishing a program from maintaining one, so a design failure and an implementation failure are now distinct findings. Resources are expected to follow risk, concentrated on higher-risk customers and activity rather than spread evenly across a checklist.

Notice what that combination does. On one side, the regulator removes the fixed thresholds and mandatory collections that told you exactly what to do. On the other, it tells you that your program will be judged on whether your own risk-based choices actually work. The prescriptive floor goes away; the effectiveness standard hardens. That is not a lighter load. It is a transfer of responsibility from the rulebook to your risk judgment.

The burden moved from the rulebook to your judgment

When a rule tells you to record every cross-border transfer at $3,000, compliance is a question of coverage: did you capture everything at or above the line. When there is no mandated line, the question changes. Now you have to decide which transfers, customers, jurisdictions, and counterparties matter for your institution, document why, and be ready to defend that reasoning to an examiner who is testing whether your program is effective rather than whether a box was checked.

The national priorities make this concrete. FinCEN updates them at least every four years, and the proposed rule says you must genuinely incorporate the ones relevant to your risk profile, not simply acknowledge that they exist. Screening against the priorities is no longer an answer by itself. Showing how your data and controls reflect the priorities that apply to your book, with evidence they are working, is the standard you are being measured against.

In a risk-based, effectiveness-driven regime, a compliance program has to be able to show four things it could previously assume:

  1. What you decided to treat as risk. The explicit scope of customers, geographies, products, and behaviors your program watches, derived from a documented risk assessment rather than from a federal threshold.
  2. Why you decided it. The rationale connecting each risk-based choice to your institution’s actual exposure and to the national priorities that apply to it. A withdrawn mandate removes the external justification; your own reasoning has to stand in its place.
  3. That it is current. Evidence the risk picture is refreshed as products, customers, and geopolitics change, not frozen at onboarding or at the date of the last exam.
  4. That it works. Proof the program is implemented in all material respects and actually surfaces the risk it claims to manage, because effectiveness is now the legal test, not a performance aspiration.

Judgment runs on data

This is the quiet consequence of a deregulatory year. As prescription recedes, the quality of your underlying data stops being a back-office concern and becomes the thing your entire program rests on. You cannot run a defensible risk-based program on thin or stale information, because every risk decision you make, and every decision you decline to make, now has to be justified on its own merits rather than by pointing to a rule that required it.

That is the layer Vital4 is built to serve. Vital4 is a compliance-data company: the authoritative-data and screening layer underneath watchlist, adverse-media, and politically-exposed-person decisions. Its patented contextualized entity extraction, granted November 25, 2025, reads unstructured content and captures the context and materiality around a name: not just that a person or entity appears somewhere, but what the appearance means and how much it matters. In a world where you have to defend why something was or was not treated as risk, that context is the difference between a risk decision you can stand behind and one you merely made.

VITAL4

Build your data layer with Vital4

REQUEST A DEMO

FAQs

On April 7, 2026, FinCEN proposed a rule that would rebuild Bank Secrecy Act program requirements around effectiveness. Financial institutions would be required to establish and maintain AML/CFT programs that are effective, risk-based and reasonably designed, with risk assessments driving where resources go. The proposal was published in the Federal Register on April 10, 2026, and public comments closed on June 9, 2026.

The proposal treats a program as effective when it is both established and maintained. Established means the institution has designed a reasonable, risk-based program with internal policies, procedures and controls. Maintained means the program is implemented in all material respects. In practice, institutions need evidence that the program works, not only that it exists.

No. In November 2026, FinCEN and the Federal Reserve withdrew a 2020 proposal that would have lowered the cross-border recordkeeping and Travel Rule threshold from $3,000 to $250 and expressly covered convertible virtual currency. The existing $3,000 threshold remains in force.

FinCEN postponed the effective date of its investment adviser AML/CFT program and suspicious activity reporting rule from January 1, 2026 to January 1, 2028. FinCEN has also said it intends to revisit the rule’s scope.

When a rule no longer sets a fixed list or threshold, the institution has to document and defend its own risk-based choices, and those choices are only as strong as the data behind them. Vital4 supplies sanctions, watchlist, PEP and adverse media data sourced directly from primary sources in 240+ countries, with Smart Monitoring alerts when records are added or changed, delivered by API and web interface.